Terms: = Cervical cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Treatment
23 results:
1. Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted car-T cell therapy: a case report.
Zhong G; Zhang X; Guo Z; Gao Y; Zhao B; Liu X; Chen L; Qiao J; Yu C; Wang L; Li Y; Yu L
Front Immunol; 2024; 15():1325860. PubMed ID: 38487523
[TBL] [Abstract] [Full Text] [Related]
2. Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment.
Wang A; Wang Y; Du C; Yang H; Wang Z; Jin C; Hamblin MR
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189058. PubMed ID: 38113952
[TBL] [Abstract] [Full Text] [Related]
3. Advances in the application of immune checkpoint inhibitors in gynecological tumors.
Zou Y; Xu Y; Chen X; Zheng L
Int Immunopharmacol; 2023 Apr; 117():109774. PubMed ID: 37012881
[TBL] [Abstract] [Full Text] [Related]
4. Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.
Zheng X; Gu H; Cao X; Pan B; Xiang H; Ju M; Xu S; Zheng M
Front Immunol; 2023; 14():1113369. PubMed ID: 36875089
[TBL] [Abstract] [Full Text] [Related]
5. Highlights into historical and current immune interventions for cancer.
Cole K; Al-Kadhimi Z; Talmadge JE
Int Immunopharmacol; 2023 Apr; 117():109882. PubMed ID: 36848790
[TBL] [Abstract] [Full Text] [Related]
6. Engineered T cell therapy for viral and non-viral epithelial cancers.
Norberg SM; Hinrichs CS
Cancer Cell; 2023 Jan; 41(1):58-69. PubMed ID: 36400016
[TBL] [Abstract] [Full Text] [Related]
7. Generation and Functional Characterization of PLAP car-T Cells against cervical cancer Cells.
Yekehfallah V; Pahlavanneshan S; Sayadmanesh A; Momtahan Z; Ma B; Basiri M
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139135
[TBL] [Abstract] [Full Text] [Related]
8. Factors associated with cervical cancer screening among women aged 25-60 years in Lao People's Democratic Republic.
Phaiphichit J; Paboriboune P; Kunnavong S; Chanthavilay P
PLoS One; 2022; 17(4):e0266592. PubMed ID: 35390098
[TBL] [Abstract] [Full Text] [Related]
9. Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities.
Xu Y; Jiang J; Wang Y; Wang W; Li H; Lai W; Zhou Z; Zhu W; Xiang Z; Wang Z; Zhu Z; Yu L; Huang X; Zheng H; Wu S
Front Immunol; 2021; 12():725330. PubMed ID: 34386017
[TBL] [Abstract] [Full Text] [Related]
10. High neutrophil-to-lymphocyte ratio is a predictor of short-term survival for patients with recurrent cervical cancer after radiation-based therapy.
Taguchi A; Nakajima Y; Furusawa A; Yoshino Y; Takao M; Kashiyama T; Kino N; Yasugi T
J Obstet Gynaecol Res; 2021 May; 47(5):1862-1870. PubMed ID: 33611808
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
Han X; Liu S; Yang G; Hosseinifard H; Imani S; Yang L; Maghsoudloo M; Fu S; Wen Q; Liu Q
Gynecol Oncol; 2021 Jan; 160(1):351-360. PubMed ID: 33092868
[TBL] [Abstract] [Full Text] [Related]
12. Novel cellular immunotherapy using NKG2D car-T for the treatment of cervical cancer.
Zhang Y; Li X; Zhang J; Mao L
Biomed Pharmacother; 2020 Nov; 131():110562. PubMed ID: 32920508
[TBL] [Abstract] [Full Text] [Related]
13. cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung cancer Antigen-1.
Marcinkowski B; Stevanović S; Helman SR; Norberg SM; Serna C; Jin B; Gkitsas N; Kadakia T; Warner A; Davis JL; Rooper L; Hinrichs CS
J Immunother Cancer; 2019 Aug; 7(1):229. PubMed ID: 31455429
[TBL] [Abstract] [Full Text] [Related]
14. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
[TBL] [Abstract] [Full Text] [Related]
15. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
Xue R; Cai X; Xu H; Wu S; Huang H
Gynecol Oncol; 2018 Sep; 150(3):412-419. PubMed ID: 29996970
[TBL] [Abstract] [Full Text] [Related]
16. A Non-Gas-Based Cryotherapy System for the treatment of cervical Intraepithelial Neoplasia: A Mixed-Methods Approach for Initial Development and Testing.
Cremer M; Paul P; Bergman K; Haas M; Maza M; Zevallos A; Ossandon M; Garai JD; Winkler JL
Glob Health Sci Pract; 2017 Mar; 5(1):57-64. PubMed ID: 28351879
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of concurrent radiotherapy and weekly paclitaxel/carboplatin therapy in cervical cancer: a retrospective study.
Chikazawa K; Netsu S; Konno R
Eur J Gynaecol Oncol; 2016 Aug; 37(4):511-516. PubMed ID: 29894076
[TBL] [Abstract] [Full Text] [Related]
18. Human Papillomavirus E6 Knockdown Restores Adenovirus Mediated-estrogen Response Element Linked p53 Gene Transfer in HeLa Cells.
Kajitani K; Honda K; Terada H; Yasui T; Sumi T; Koyama M; Ishiko O
Asian Pac J Cancer Prev; 2015; 16(18):8239-45. PubMed ID: 26745067
[TBL] [Abstract] [Full Text] [Related]
19. Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.
Ramondetta LM; Meyer LA; Schmeler KM; Daheri ME; Gallegos J; Scheurer M; Montealegre JR; Milbourne A; Anderson ML; Sun CC
Gynecol Oncol; 2015 Dec; 139(3):500-5. PubMed ID: 26498912
[TBL] [Abstract] [Full Text] [Related]
20. [High Mobility Group Chromosal Protein N2 Is Expected to be as A Target of Cellular Immunetherapy in Leukemia and Tumors].
Li HH; Zhu P; Wu XQ; Liu YF; Wang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):915-8. PubMed ID: 26314417
[TBL] [Abstract] [Full Text] [Related]
[Next]
